4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Galmed Pharmaceuticals Ltd. (GLMD) operates in the Biotechnology industry and is headquartered in Ramat Gan, Israel with about 3 employees. Its market capitalization is roughly $4 million. In the fiscal year ended 2025-12-31, GLMD reported $0M in revenue and ($10M) in net income.
Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases and related indications.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($8M) | ($6M) | ($8M) | ($18M) |
| Net Income | ($10M) | ($8M) | ($7M) | ($18M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($3M) | ($2M) | ($2M) | ($1M) | ($2M) |
| Net Income | ($5M) | ($2M) | ($2M) | ($1M) | ($3M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $19M | $18M | $17M | $17M | — |
| Total Liabilities | $3M | $2M | $3M | $3M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive GLMD viewer.
About TickerBase · Data methodology & sources